FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to composite nanostructures applicable for photodynamic diagnosis of malignant tumours. The declared nanostructures represent gold-silver nanocells coated by silicone dioxide formed by tetraethylortosilicate hydrolysis in an alcohol medium The silicone dioxide coating surface is functionalised by itterbium 2,4-dimethoxyhematoporfirine.
EFFECT: preparing the composite nanoparticles combining plasma resonance within biotissue transparency (760-1000 nm), fluorescence in visible and near IR spectrum, photogeneration of singlet oxygen, increased collection in new growths.
7 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR PRODUCING COMPOSITE NANOSTRUCTURES: SILICON DIOXIDE - SILVER | 2017 | 
 | RU2643697C1 | 
| NANOCOMPOSITES FOR MAGNETOLUMINESCENT THERANOSTICS OF NEOPLASMS | 2021 | 
 | RU2766513C1 | 
| PHARMACEUTICAL COMPOSITION FOR FLUORESCENT DIAGNOSTICS OF PATHOLOGICAL CHANGES IN SKIN AND MUCOUS MEMBRANES | 2016 | 
 | RU2617045C1 | 
| METHOD OF MAKING POWDER PREPARATION OF NOBLE METAL NANOPARTICLES | 2011 | 
 | RU2489231C1 | 
| NANOCOMPOSITION FOR FLUORESCENT DIAGNOSIS OF MALIGNANT TUMOURS | 2014 | 
 | RU2578976C2 | 
| METHOD OF SELECTIVE LASER PHOTOTHERMOLYSIS OF CANCER CELLS BY PLASMON RESONANCE NANOPARTICLES | 2015 | 
 | RU2653801C1 | 
| METHOD FOR SELECTIVE DESTRUCTION OF MELANOMA | 2007 | 
 | RU2347563C1 | 
| METHOD FOR HYBRID PLASMON-LUMINESCENT MARKERS PRODUCTION | 2015 | 
 | RU2614245C1 | 
| METHOD OF LASER PHOTOTHERMOLYSIS OF CANCER CELLS | 2009 | 
 | RU2424831C1 | 
| YTTERBIUM COMPLEX OF 2,4-DIMETHOXYHEMATOPORPHYRIN IX DIPOTASSIUM SALT AS FLUORESCENT TAG FOR EARLY CANCER DIAGNOSIS | 2009 | 
 | RU2411243C1 | 
Authors
Dates
2012-10-10—Published
2011-05-05—Filed